Drug delivery and formulations for the topical treatment of psoriasis

被引:33
作者
Su, Yu-Han [1 ]
Fang, Jia-You [1 ]
机构
[1] Chang Gung Univ, Pharmaceut Lab, Grad Inst Nat Prod, Tao Yuan 333, Taiwan
关键词
dermatology; formulation; psoriasis; skin; topical delivery;
D O I
10.1517/17425247.5.2.235
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Psoriasis is one of the most common human skin diseases. It is characterised by excessive growth and aberrant differentiation of corneocytes, but is fully reversible with appropriate therapy. Objective: There are many drug therapies for psoriasis via the topical delivery route. This review describes the topically applied drugs used to treat psoriasis. Methods: Formulations to carry or encapsulate these drugs are introduced in this review. Enhancing approaches such as liposome inclusion, iontophoresis and laser are also discussed. Conclusion: This review summarises developments in the design of formulations in the area of topical drug delivery for treating psoriasis.
引用
收藏
页码:235 / 249
页数:15
相关论文
共 115 条
[1]  
*ALL, 1995, PK95022 ALL
[2]   Passive and iontophoretic transdermal penetration of methotrexate [J].
Alvarez-Figueroa, MJ ;
Delgado-Charro, MB ;
Blanco-Méndez, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (01) :101-107
[3]   Transdermal delivery of methotrexate:: iontophoretic delivery from hydrogels and passive delivery from microemulsions [J].
Alvarez-Figueroa, MJ ;
Blanco-Méndez, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 215 (1-2) :57-65
[4]  
Asbill CS, 2000, CRIT REV THER DRUG, V17, P621
[5]   Influence of lipophilic counter-ions in combination with phloretin and 6-ketocholestanol on the skin permeation of 5-aminolevulinic acid [J].
Auner, BG ;
Valenta, C ;
Hadgraft, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 255 (1-2) :109-116
[6]  
Barker JNWN, 1999, BRIT J DERMATOL, V141, P274
[7]   THE PATHOPHYSIOLOGY OF PSORIASIS [J].
BARKER, JNWN .
LANCET, 1991, 338 (8761) :227-230
[8]   Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel [J].
Behrens, S ;
Grundmann-Kollmann, M ;
Schiener, R ;
Peter, RU ;
Kerscher, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) :493-495
[9]   Vitamin D3-based conjugates for topical treatment of psoriasis:: Synthesis, antiproliferative activity, and cutaneous penetration studies [J].
Ben-Shabat, S ;
Benisty, R ;
Wormser, U ;
Sintov, AC .
PHARMACEUTICAL RESEARCH, 2005, 22 (01) :50-57
[10]   The genetics of psoriasis: a complex disorder of the skin and immune system [J].
Bhalerao, J ;
Bowcock, AM .
HUMAN MOLECULAR GENETICS, 1998, 7 (10) :1537-1545